| Primary |
| Hypertension |
18.3% |
| Maternal Exposure Timing Unspecified |
13.3% |
| Intentional Overdose |
8.3% |
| Product Used For Unknown Indication |
8.3% |
| Atrial Fibrillation |
7.5% |
| Blood Pressure Increased |
7.5% |
| Overdose |
7.5% |
| Drug Use For Unknown Indication |
6.7% |
| Headache |
5.0% |
| Ill-defined Disorder |
3.3% |
| Heart Rate Irregular |
2.5% |
| Supraventricular Tachycardia |
2.5% |
| Blood Pressure |
1.7% |
| Cluster Headache |
1.7% |
| Suicide Attempt |
1.7% |
| Arthritis |
0.8% |
| Atrial Flutter |
0.8% |
| Blood Glucose Increased |
0.8% |
| Blood Pressure Abnormal |
0.8% |
| Extrasystoles |
0.8% |
|
| Completed Suicide |
30.4% |
| Drug Toxicity |
12.0% |
| Vomiting |
6.5% |
| Death |
5.4% |
| Respiratory Arrest |
5.4% |
| Premature Baby |
4.3% |
| Shock |
4.3% |
| Asthenia |
3.3% |
| Hypotension |
3.3% |
| Lethargy |
3.3% |
| Medication Error |
3.3% |
| Ventricular Hypokinesia |
3.3% |
| Wrong Drug Administered |
3.3% |
| Dyspnoea |
2.2% |
| Myositis |
2.2% |
| Overdose |
2.2% |
| White Blood Cell Count Increased |
2.2% |
| Accidental Exposure |
1.1% |
| Amnesia |
1.1% |
| Angioedema |
1.1% |
|
| Secondary |
| Product Used For Unknown Indication |
23.4% |
| Hypertension |
16.4% |
| Drug Use For Unknown Indication |
14.9% |
| Atrial Fibrillation |
8.1% |
| Arrhythmia |
4.9% |
| Migraine |
4.7% |
| Depression |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Emphysema |
2.8% |
| Type 2 Diabetes Mellitus |
2.5% |
| Angina Pectoris |
2.1% |
| Osteoporosis |
2.1% |
| Ill-defined Disorder |
1.7% |
| Vasospastic Angina |
1.7% |
| Cardiac Disorder |
1.5% |
| Muscle Spasms |
1.5% |
| Asthma |
1.3% |
| Hypersensitivity |
1.1% |
| Sedation |
1.1% |
| Diabetes Mellitus |
0.9% |
|
| Completed Suicide |
8.3% |
| Blood Pressure Increased |
7.1% |
| Shock |
7.1% |
| Torsade De Pointes |
7.1% |
| Vomiting |
7.1% |
| Metabolic Alkalosis |
6.0% |
| Platelet Count Decreased |
6.0% |
| Tonic Convulsion |
6.0% |
| Hallucination |
4.8% |
| Thrombocytopenia |
4.8% |
| Ventricular Flutter |
4.8% |
| Death |
3.6% |
| Hepatitis Cholestatic |
3.6% |
| Hypoxia |
3.6% |
| Renal Failure |
3.6% |
| Syncope |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Ventricular Tachycardia |
3.6% |
| Weight Decreased |
3.6% |
| Acute Myocardial Infarction |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.0% |
| Hypertension |
14.6% |
| Rheumatoid Arthritis |
12.7% |
| Product Used For Unknown Indication |
10.7% |
| Atrial Fibrillation |
4.6% |
| Asthma |
4.2% |
| Diabetes Mellitus |
3.6% |
| Osteoporosis |
2.8% |
| Prophylaxis |
2.6% |
| Arrhythmia |
2.4% |
| Pain |
2.4% |
| Depression |
1.9% |
| Dyslipidaemia |
1.7% |
| Type 2 Diabetes Mellitus |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Insomnia |
1.5% |
| Back Pain |
1.4% |
| Constipation |
1.4% |
| Multiple Myeloma |
1.4% |
| Thyroid Disorder |
1.3% |
|
| Vomiting |
15.9% |
| Renal Impairment |
9.1% |
| Weight Increased |
7.9% |
| White Blood Cell Count Decreased |
7.3% |
| Sepsis |
5.5% |
| Weight Decreased |
5.5% |
| Respiratory Failure |
4.9% |
| Pyrexia |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Renal Failure Chronic |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Hyperkalaemia |
3.0% |
| Injection Site Pain |
3.0% |
| Oedema Peripheral |
3.0% |
| Pneumonia |
3.0% |
| Renal Failure |
3.0% |
| Rhabdomyolysis |
3.0% |
| Sinus Disorder |
3.0% |
| Vision Blurred |
3.0% |
|
| Interacting |
| Diabetes Mellitus |
21.7% |
| Periodontitis |
17.4% |
| Hypertension |
13.0% |
| Arrhythmia |
8.7% |
| Blood Pressure |
8.7% |
| Glaucoma |
8.7% |
| Myocardial Ischaemia |
8.7% |
| Erectile Dysfunction |
4.3% |
| Ill-defined Disorder |
4.3% |
| Prostatomegaly |
4.3% |
|
| Shock |
25.0% |
| Drug Ineffective |
12.5% |
| Nocturia |
12.5% |
| Palpitations |
12.5% |
| Periodontitis |
12.5% |
| Pulmonary Oedema |
12.5% |
| Sudden Death |
12.5% |
|
